Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL)

10.1002/pbc.20684

Saved in:

Bibliographic Details
Main Authors:	Kwok, C.S., Kham, S.K., Quah, T.C., Yeoh, A.E., Ariffin, H., Lin, H.P.
Other Authors:	PAEDIATRICS
Format:	Article
Published:	2011
Subjects:	ALL Drug efficacy L-asparaginase Leukemia Minimal residual disease
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/25684
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-25684
record_format	dspace
spelling	sg-nus-scholar.10635-256842023-10-30T07:13:01Z Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL) Kwok, C.S. Kham, S.K. Quah, T.C. Yeoh, A.E. Ariffin, H. Lin, H.P. PAEDIATRICS ALL Drug efficacy L-asparaginase Leukemia Minimal residual disease 10.1002/pbc.20684 Pediatric Blood and Cancer 47 3 299-304 2011-08-16T07:43:11Z 2011-08-16T07:43:11Z 2006 Article Kwok, C.S., Kham, S.K., Quah, T.C., Yeoh, A.E., Ariffin, H., Lin, H.P. (2006). Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL). Pediatric Blood and Cancer 47 (3) : 299-304. ScholarBank@NUS Repository. https://doi.org/10.1002/pbc.20684 15455009 15455017 http://scholarbank.nus.edu.sg/handle/10635/25684 000239359300016 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	ALL Drug efficacy L-asparaginase Leukemia Minimal residual disease
spellingShingle	ALL Drug efficacy L-asparaginase Leukemia Minimal residual disease Kwok, C.S. Kham, S.K. Quah, T.C. Yeoh, A.E. Ariffin, H. Lin, H.P. Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL)
description	10.1002/pbc.20684
author2	PAEDIATRICS
author_facet	PAEDIATRICS Kwok, C.S. Kham, S.K. Quah, T.C. Yeoh, A.E. Ariffin, H. Lin, H.P.
format	Article
author	Kwok, C.S. Kham, S.K. Quah, T.C. Yeoh, A.E. Ariffin, H. Lin, H.P.
author_sort	Kwok, C.S.
title	Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL)
title_short	Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL)
title_full	Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL)
title_fullStr	Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL)
title_full_unstemmed	Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL)
title_sort	minimal residual disease (mrd) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using escherichia coli-asparaginase or erwinia-asparaginase in childhood acute lymphoblastic leukemia (all)
publishDate	2011
url	http://scholarbank.nus.edu.sg/handle/10635/25684
_version_	1781410432722927616

Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL)

Similar Items